Imagine that your company is preparing to launch a new branded drug with distinct advantages in efficacy and side-effect profile. You are challenged by a crowded market dominated by generics. Ninety-six percent of the market share is shared across multiple generics; three other branded products compete for the remaining 4%. The market value is high, so dominating the branded competitors is not only a significant...
Read More
Over the past decade, the distribution model for medication delivery has evolved from retail pharmacies and mail order to Specialty Pharmacies (SP), 340B Contract Pharmacies, and Rare Disease Pharmacies. In addition, large health systems are continuing the trend of market consolidation by purchasing physician practices, smaller regional hospitals, long-term care facilities and other ancillary healthcare services. These health systems are using their size and influence...
Read More